SCHEMBL21390353

SCHEMBL21390353

O=C1COC2CCN(C(=O)N3CC(c4ccc(N5CC(C(F)(F)F)C5)cc4)C3)CC2N1

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 10/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23149008 1.00 MGLL (0.65) MGLL
SCHEMBL29849768 0.94 MGLL (0.63) MGLL
SCHEMBL21390129 0.94 MGLL (0.63) MGLL
SCHEMBL25057257 0.94 MGLL (0.63) MGLL
SCHEMBL21390131 0.94 MGLL (0.63) MGLL
SCHEMBL21385287 0.94 MGLL (0.63) MGLL
SCHEMBL21390446 0.91 MGLL (0.66) MGLL
SCHEMBL23148988 0.91 MGLL (0.66) MGLL
SCHEMBL23149016 0.89 MGLL (0.65) MGLL
SCHEMBL21390435 0.89 MGLL (0.65) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3768684-B1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS HOFFMANN LA ROCHE (CH) 2023-02-22 — — EP disclosed
WO-2019180185-A1 OXAZINE MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2019-09-26 — — WO disclosed
Send feedback